Irlande -
anglais -
HPRA (Health Products Regulatory Authority)
calcium resonium 99.934 % powder for oral or rectal suspension
sanofi-aventis ireland limited t/a sanofi - calcium polystyrene sulphonate - powder for oral/rectal suspension - 99.934 percent weight/weight - drugs for treatment of hyperkalemia and hyperphosphatemia; polystyrene sulfonate
Israël -
anglais -
Ministry of Health
kayexalate
sanofi israel ltd - polystyrene sulphonate sodium - powder for suspension - polystyrene sulphonate sodium 99.934 % - polystyrene sulfonate - polystyrene sulfonate - treatment of hyperkalemia.
Malte -
anglais -
Medicines Authority
sorbisterit, powder for oral/rectal suspension
fresenius medical care nephrologica deutschland gmbh d-61346 bad homburg, germany - calcium - powder for oral suspension - calcium 1.8 mmol/g - all other therapeutic products
Royaume-Uni -
anglais -
MHRA (Medicines & Healthcare Products Regulatory Agency)
calcium resonium powder
sanofi - calcium polystyrene sulfonate - powder for oral or rectal suspension - 999mg/1gram
Royaume-Uni -
anglais -
MHRA (Medicines & Healthcare Products Regulatory Agency)
calcium resonium powder
lexon (uk) ltd - calcium polystyrene sulfonate - powder for oral or rectal suspension - 999mg/1gram
Royaume-Uni -
anglais -
MHRA (Medicines & Healthcare Products Regulatory Agency)
sorbisterit powder
stanningley pharma ltd - calcium polystyrene sulfonate - powder for oral or rectal suspension - 854mg/1gram
Irlande -
anglais -
HPRA (Health Products Regulatory Authority)
sevelamer hydrochloride waymade 400 mg film-coated tablets
waymade b.v. - sevelamer hydrochloride - film-coated tablet - 400 milligram(s) - drugs for treatment of hyperkalemia and hyperphosphatemia; sevelamer
Irlande -
anglais -
HPRA (Health Products Regulatory Authority)
sevelamer hydrochloride waymade 800 mg film-coated tablets
waymade b.v. - sevelamer hydrochloride - film-coated tablet - 800 milligram(s) - drugs for treatment of hyperkalemia and hyperphosphatemia; sevelamer
Union européenne -
anglais -
EMA (European Medicines Agency)
fexeric
akebia europe limited - ferric citrate coordination complex - hyperphosphatemia; renal dialysis - drugs for treatment of hyperkalaemia and hyperphosphataemia - fexeric is indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease (ckd).
Union européenne -
anglais -
EMA (European Medicines Agency)
renagel
sanofi b.v. - sevelamer - renal dialysis; hyperphosphatemia - all other therapeutic products - renagel is indicated for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.renagel should be used within the context of a multiple therapeutic approach, which could include calcium supplements, 1,25 - dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.